Calendrier des promotions DURECT Corporation
Calendrier avancé
Graphique simple
À propos de l'entreprise DURECT Corporation
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.Paramètres de base
IPO date
2000-09-28
ISIN
US2666051048
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 12.95 | 1 |
P/BV | 2.88 | 6 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | -26.2 | 0 |
ROE | -68.52 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | -0.1166 | 10 |
Debt/Ratio | 0.1202 | 10 |
Debt/Equity | 1.01 | 8 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | -93.25 | 0 |
Rentabilité Ebitda, % | 56.3 | 7 |
Rentabilité EPS, % | 112.85 | 10 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 0.615 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 0.6 $ | 0 $ | 0 $ | 2.5 % | 0 % | 0 % |
common.calendar.number_days.30d | 0.544 $ | 0.541 $ | 0.64 $ | 13.05 % | 0 % | 0 % |
common.calendar.number_days.90d | 0.749 $ | 0.4999 $ | 0.8 $ | -17.89 % | 0 % | 0 % |
common.calendar.number_days.180d | 0.76 $ | 0.4999 $ | 0.87 $ | -19.08 % | 0 % | 0 % |
common.calendar.number_days.1y | 1.39 $ | 0.4999 $ | 1.67 $ | -55.76 % | 0 % | 0 % |
common.calendar.number_days.3y | 7.83 $ | 0.425 $ | 8.72 $ | -92.15 % | 0 % | 0 % |
common.calendar.number_days.5y | 2.32 $ | 0.3764 $ | 8.72 $ | -73.43 % | 0 % | 0 % |
common.calendar.number_days.10y | 0.3764 $ | 0.3764 $ | 8.72 $ | 163.39 % | 0 % | 0 % |
common.calendar.number_days.ytd | 0.7502 $ | 0.4999 $ | 0.87 $ | -18.02 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Dr. James E. Brown D.V.M. | Co-Founder, CEO, President & Director | 633.46k | 1957 (68 années) |
Ms. Judy R. Joice | Senior Vice President of Operations & Corporate Quality Assurance | 451.82k | 1957 (68 années) |
Dr. Norman L. Sussman M.D. | Chief Medical Officer | 471.71k | 1953 (72 année) |
Mr. Timothy M. Papp M.B.A. | CFO & Secretary | 427.62k | 1976 (49 années) |
Ms. Jian Li M.B.A. | Senior VP of Finance, Corporate Controller & Secretary | 297.08k | 1970 (55 années) |
Dr. WeiQi Lin M.D., Ph.D. | Executive VP of Research & Development and Principal Scientist | N/A | |
Mr. Keith L. Lui M.B.A. | Senior Vice President of Business Development, Commercial & Medical Affairs | N/A | |
Dr. Su Il Yum Ph.D. | Executive Officer | 331.74k | 1939 (86 années) |
Informations sur l'entreprise
Adresse: United States, Cupertino. CA -, 10260 Bubb Road - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.durect.com
Site web: https://www.durect.com